Amryt Pharma

Ireland’s Mr IPO and his plans to make more companies public

Cathal Friel shows no sign of slowing down after a busy week which saw him sell his remaining stake in Hvivo

Tue Jul 30 2024 - 05:54

Poolbeg Pharma expands treatment into new markets

Company signs strategic collaboration agreement with a Nasdaq listed biopharma company

Tue Apr 30 2024 - 12:46

Upcoming Irish and overseas elections may affect M&A activity this year, William Fry warns

Falling interest rates may offer some support but acquirers are wary of policy changes here and abroad

Thu Feb 15 2024 - 05:00

Cathal Friel-chaired green metals company hires broker for London IPO

Flotation of Irish-run company could take place as soon as March

Wed Jan 31 2024 - 06:00

Life sciences a rare bright spot in muted Irish M&A activity last year - EY

Deal volumes in the Republic were down in 2023 but in value terms were up nearly 600 per cent year on year, according to EY analysis

Mon Jan 22 2024 - 05:00

Irish deal-making ‘muted’ amid global slump

Value of M&A transactions fell 58% to €5.2bn in first half, says William Fry

Tue Aug 08 2023 - 10:35

Amryt pays dividends for big investors

US funds make $79m profit on investment in Irish rare disease drug developer, and could yet make another $62.5m

Sat Jan 14 2023 - 05:55

Amryt strikes gold with rare-disease breakthrough

Irish pharma company secures a 100%-plus premium for shareholders in deal to sell the business to bigger Italian rival

Tue Jan 10 2023 - 05:40

Irish rare disease drugmaker Amryt Pharma to be acquired for up to €1.4bn

Eight-year old Amryt got EU approval last year for first treatment for rare genetic condition known as butterfly skin disease that primarily affects children

Mon Jan 09 2023 - 09:10

Rare disease specialist Amryt lost €65m last year

Irish drug-maker plans to return $30m to investors

Wed Mar 09 2022 - 18:51

Amryt announces plan to delist from AIM in London

Drug firm says says delisting would enhance liquidity of trading

Mon Nov 22 2021 - 07:33

Irish pharma group Amryt reports 15% revenue growth for third quarter

Rare disease specialist says performance was ‘strong’ in ‘extremely busy’ period

Wed Nov 03 2021 - 13:12

Amryt Pharma granted priority review of ‘butterfly skin’ treatment

US Food and Drug Administration’s priority review can expedite review process to six months

Thu Jun 03 2021 - 07:35

Amryt progresses with bid to win US approval for ‘butterfly skin’ treatment

Rolling submission began last summer

Wed Mar 31 2021 - 15:04

Butterfly skin drug group Amryt announces €33m fundraise

Placing of shares comes ahead of submission to regulators for approval of drug for rare condition

Tue Dec 08 2020 - 12:46

Biopharma group Amryt reports 19% jump in revenue in third quarter

Results are a record for Dublin-based company, which has recently listed on Nasdaq

Thu Nov 05 2020 - 19:32

Amryt signs agreement to distribute Lojuxta

Swixx BioPharma will sell cholesterol drug across central and eastern Europe

Mon Oct 19 2020 - 07:31

Amryt shares surge on success in drug trial for ‘butterfly skin’

Irish specialist in rare diseases says successful drug could tap $1bn market

Wed Sept 09 2020 - 19:07

EY Entrepreneur of the Year international finalists focusing on growth

Sectors include health and safety, pharma, crop protection and refrigeration

Sat Sept 05 2020 - 05:00

Investor exercises rights to 4m Amryt warrants

Warrants were issued in September as part of the company’s acquisition of Aegerion

Fri Jul 10 2020 - 15:48

Irish pharma company Amryt almost doubles CEO pay to $1.6m

Chief executive Joe Wiley also received more than 6m share options in company

Tue Jun 30 2020 - 12:39

Amryt Pharma files registration statement for impending Nasdaq listing

Company recently signed distribution agreement with Swixx BioPharma

Wed Jun 24 2020 - 08:19

Biopharma group Amryt reports 30% jump in revenue

Rare disease specialist says integration with newly acquired Aegerion completed ahead of time

Mon May 11 2020 - 09:20

Amryt Pharma recorded 13.1% rise in revenue last year

Company said the impact of Covid-19 on its business has been minimised so far

Mon Mar 23 2020 - 12:06

Amryt says integration of acquired company Aegerion ‘progressing well’

Dublin-based biopharma company has cash position of $60.9m

Thu Dec 19 2019 - 08:26

‘Serious gender imbalance’ remains at top of Irish business, report finds

New targets set for inclusion of women on leadership teams and in private companies

Wed Dec 11 2019 - 05:23

Dublin pharma company Amryt grows sales almost 20%

Firm acquired US-based Aegerion Pharmaceuticals earlier this year

Tue Nov 05 2019 - 10:09

Venn signs deal with Open Orphan to focus on rare diseases

Company has issued €1.1m in loan notes to fund specialisation in orphan diseases

Tue Dec 11 2018 - 07:43

Iseq slumps to lowest since Brexit referendum as key vote delayed

Markets also rattled by growing unrest in France and fresh China-US trade concerns

Mon Dec 10 2018 - 18:15

Government provides €75m in funding for ‘disruptive’ projects

Company that received the most funding was biopharmaceutical group Amryt Pharma

Mon Dec 10 2018 - 14:52

Carrick Therapeutics head Sullivan named best emerging entrepreneur

Elaine Sullivan leads cancer research firm to an EY Entrepreneur of the Year Award

Thu Oct 25 2018 - 19:00

Irish shares advance for first time in five sessions

European markets buoyed by speculation that US could resume trade talks with China

Wed Sept 26 2018 - 19:26

Sales of Amryt Pharma cholesterol drug up 14.6%

Amyrt’s EB development asset progressing through phase three clinical trial

Wed Sept 26 2018 - 08:01

Amryt skin therapy trial gets green light in US

Approval for treatment for rare genetic condition paves way for clinical trials in US

Mon Sept 10 2018 - 07:27